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Bovine herpesvirus 1 (BoHV-1), classified as a
member of the family Herpesviridae, subfamily
Alphaherpesvirinae, genus Varicellovirus (1), is the
causative agent of several infections from the
respiratory and genital tracts of domestic cattle and
other ruminant species. Based on Western Blot
analysis of viral proteins with a panel of monoclonal
antibodies, as well as on restriction endonuclease
analysis of the viral nucleic acid and differential
amplification by PCR (2, 3, 4), BoHV-1 strains are
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ABSTRACT: In Cuba, infections caused by Bovine herpesvirus 1 (BoHV-1) are endemic; however clinical
signs are moderate, possibly because the BoHV-1 circulating genotypes are not associated to severe
infections but these are not known. In the present study a BoHV-1 strain isolated in Cuba was compared
with BoHV-1 strains from other different countries. Viral DNA was analysed by adoption of a clustering
system based on restriction enzyme analysis (REA) with HindIII, HpaI, PstI and SfiI, which led to identify
the Cuban isolate as a BoHV-1.1.III strain. The Cuban BoHV-1 differed from all the reference strains
analysed and displayed a restriction fragment pattern more similar to strains originated from the
European continent. The inclusion of these results into the clustering database is a contribution for
future studies in tracing back the origin of novel infectious bovine rhinotracheitis (IBR) outbreaks.
(Key words: Bovine herpesvirus 1; infectious bovine rhinotracheitis; restriction enzyme analysis; clustering
system)
CARACTERIZACIÓN MOLECULAR DE UNA CEPA CUBANA
DE Herpesvirus bovino 1
RESUMEN: En Cuba, las infecciones causadas por Herpesvirus bovino 1 (BoHV-1) son endémicas; sin
embargo los signos clínicos son moderados, posiblemente porque los genotipos circulantes de BoHV-1
no están asociados con infecciones severas pero estos no se conocen. En el presente estudio se comparó
un aislado de BoHV-1 proveniente de Cuba con cepas de BoHV-1 de diferentes países. El ADN viral fue
analizado por adopción de un sistema de agrupamiento basado en análisis de restricción (REA) con las
enzimas HindIII, HpaI, PstI y SfiI, el cual permitió identificar el aislado cubano como una cepa de
BoHV-1.1.III. El BoHV-1 cubano difirió de todas las cepas de referencias analizadas y mostró un patrón
de restricción similar a cepas provenientes del continente europeo. La introducción de estos resultados
en la base de datos de agrupamiento es una contribución para futuros estudios relacionados con el origen
de nuevos brotes de rinotraqueitis infecciosa bovina (RIB).
(Palabras clave: Herpesvirus bovino 1; rinotraqueitis infecciosa bovina; análisis de restricción; sistema de
agrupamiento)
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classified into two subtypes, BoHV-1.1 and BoHV-1.2,
BoHV-1.2 being additionally grouping into BoHV-1.2a
and BoHV-1.2b.
In Cuba, studying BoHV-1 and other cattle
pathogens has been limited by economic problems.
Nowadays, the interest in cattle production is
increasing, and gaining profound knowledge on the
epidemiological status of the BoHV-1 infection is
getting importance. This implies the characterization
of BoHV-1 strains that are circulating in the country.
The purpose of the present study was to compare a
BoHV-1 isolate from Cuba with BoHV-1 strains from
other different countries using a clustering system
based on restriction enzyme analysis.
Madin-Darby bovine kidney cells (MDBK; ATCC
CCL 22) were grown in Eagle’s minimal essential
medium (Eagle’s MEM, BioConcept’s AMIMED,
Switzerland) supplemented with 100 IU mL-1 penicillin,
100 mg mL-1 streptomycin and 7% foetal calf serum
(FCS, Omnilab, Switzerland). In the maintenance
medium, FCS was reduced to 2%. The cells were used
for virus stocks production of the Cuban BoHV-1 strain
E8, isolated in 1984 during an outbreak of
keratoconjunctivitis (5) and BoHV-1 reference strains
previously characterized by Wyss (6) (Table 1).
Virus purification and DNA extraction were
conducted as previously described by Engels et al (7).
DNA concentrations were determined by reading of
absorbance at 260 nm (NanoDrop Technologies, Inc.,
Witec NanoDrop® ND-1000 Spectrophotometer®). The
absorbance ratio 260/280 nm was always between
1.93 and 2.
Aliquots containing 2 mg DNA were digested for 2
hr with HindIII, HpaI, PstI (Roche) and SfiI (BioLabs),
respectively, under conditions recommended by the
supplier in a final volume of 20 mL. The digestion
products were separated by electrophoresis in 0.8%
agarose gels containing 1 mg mL-1 ethidium bromide
solution (BioRad). Gels were electrophoresed in TAE
electrophoresis buffer (4 mM Tris-acetate, 1 mM
EDTA; pH 8.0) between 18 and 24 hr at 60 V. For
determinating the DNA fragment sizes, 1 Kb DNA
Ladder (Gibco) with a size range of 500 bp to 12 kb
and high molecular weight DNA markers (Invitrogen)
with a size range of 9 kb to 48 kb were included. The
bands were visualized and photographed using
Quantity One® (Bio-Rad Laboratories, BioRad) and the
molecular characterization was based on the clustering
system by Wyss (6).
Comparative analysis of the resulting restriction
enzyme patterns revealed that E8 HindIII pattern was
more similar to one Canadian strain (BoHV-1 V214)
and two European strains (BoHV-1 599/97 and BoHV-
1 Cu7) (see Fig. 1A). As all those strains belonged to
the BoHV-1.1 genotype, it was concluded that E8
belonged to the same genotype. Furthermore, isolate
E8 was identified as BoHV-1.1.III strain, based on
HindIII fragments E and F which appeared merging,
TABLE 1. BoHV-1 reference strains./ Cepas de referencia de BoHV-1 
 
 Numeric code Designation Year Country of 
origin 
Subtype 
HindIII HpaI PstI SfiI 
Cu7 1977 Belgium 1.1.III 931 421 125123 431231 
V214 1993 Canada 1.1.I 931 421 125124 431221 
VI 273/97 1997 Germany  1.1.IIb 931 421 122224 421221 
7624/97 1997 Germany 1.1.IIa 921 421 122224 421221 
9389/97 1997 Germany 1.2.a.III 931 421 122124 421221 
VI 599/97 1997 Germany 1.1.II 931 421 023224 531221 
Roma 1963 Italy 1.1.IIIc 921 4 112xxx xxxxxx 
Jura 1978 Switzerland 1.1.I 931 421 122124 431221 
Miggi 1982 Switzerland 1.2a.IV 931 4 113125 331221 
94-12508 (USA 3) - U.S.A 1.1.I 931 322 124124 421221 
85-24083 
(USA 11) 
1985 U.S.A 1.1.Ib 931 421 023224 630231 
Bovilis® - Vaccine 1.2a.I 931 421 121124 431231 
Riemser® - Vaccine 1.1.Ia 931 4 132114 321242 
     
 
 
 
- Not reported 
x No results 
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and fragments C and D which showed higher
molecular weight than the corresponding fragments
of the other BoHV-1 strains.
Seven bands were obtained by E8 digestion with
HpaI (see Fig. 1B). These results corresponded to the
numeric code 421 based on the number of bands
observed in clusters 1, 2 and 3, respectively.
E8 PstI pattern corresponded to the numeric code
125124. This code was also obtained from BoHV-1
V214, but differences in the molecular weight of the
band 4 of cluster 6 were found (see Fig. 1C). Five
fragments from E8 viral DNA were observed in cluster
3 and these were not observed from the American
strain USA3 with 2 and 4 bands, respectively.
Furthermore, bands 3, 4 and 5 of cluster 3 were
observed at similar intensity for E8, and differences
were found in BoHV-1 strains V214 and Cu7.
As it can be seen in Fig. 1D, the numeric code
421221 can be assigned to E8 SfiI pattern. It was more
similar to the BoHV-1 strains V214 but only two bands
in cluster 2 were obtained.
Restriction fragment pattern analysis has mostly
been used for classification purposes knowing that the
highest differences between BoHV-1.1 and BoHV-1.2
are restricted to distinct genomic regions characterized
by loss or gain of restriction sites (8). It has also been
used to differentiate between vaccine and field strains
of BoHV-1 according to Hamelin et al (9). Moreover,
according to systematic sequencing of individual
isolates will be difficult to perform due to the high G +
C content of BoHV-1 genomes (1), it is recommended
the adoption of a clustering system based on restriction
endonuclease analysis with enzymes HindIII, HpaI,
PstI and SfiI in order to identifying the possible origins
of BoHV-1 strains (6). This methodology was
previously used to the identification of BoHV-1 strain
origin, which had been isolated from imported semen
and which had led to a new outbreak in 1983 in
Switzerland (10).
The clustering data base includes about 100
different BoHV-1 strains previously analyzed by Wyss
(6); in there, BoHV-1.1.III subtype corresponds with
the 16% of BoHV-1.1 strains. It is important to note
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FIGURE 1A. Restriction enzyme analysis of DNA from BoHV-1 strains with HindIII. 1: V214 strain; 2: Vaccine strain
Riemser; 3: USA 11 strain; 4: VI 599/97 strain; 5: 7624/97 strain; 6: VI 273/97 strain; 7: Cu7 strain; 8: Roma strain; 9:
Vaccine strain Bovilis; 10: 9389/97 strain; 11: Miggi strain; 12: Sm2 strain; 13: E8 strain; M1: 1 kb molecular weight
marker; M2: High Molecular Weight DNA Markers. Cl. Cluster. Arrows indicate the differences between BoHV-1 strains./
Análisis con enzimas de restricción del ADN de cepas de BoHV-1 con HindIII. 1: Cepa V214; 2: Cepa vacunal Riemser;
3: Cepa USA 11; 4: Cepa VI 599/97; 5: Cepa 7624/97; 6: Cepa VI 273/97; 7: Cepa Cu7; 8: Cepa Roma; 9: Cepa vacunal
Bovilis; 10: Cepa 9389/97; 11: Cepa Miggi; 12: Cepa Sm2; 13: Cepa E8; M1: Marcador de peso molecular de 1 kb; M2:
Marcador de ADN de alto peso molecular. Cl. Grupo. Las flechas indican lãs diferencias entre cepas de BoHV-1.
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FIGURE 1B. Restriction enzyme analysis of DNA
from BoHV-1 strains with HpaI. 1: V214 strain; 2:
USA 11 strain; 3: VI 599/97 strain; 4: 7624/97 strain;
5: VI 273/97 strain; 6: Cu7 strain; 7: Vaccine strain
Bovilis; 8: 9389/97 strain; 9: E8 strain; M: 1 kb
molecular weight marker. Cl. Cluster./ Análisis con
enzimas de restricción del ADN de cepas de BoHV-
1 con HpaI. 1: Cepa V214; 2: Cepa USA 11; 3: Cepa
VI 599/97; 4: Cepa 7624/97; 5: Cepa VI 273/97; 6:
Cepa Cu7; 7: Cepa vacunal Bovilis; 8: Cepa 9389/
97; 9: Cepa E8; M: Marcador de peso molecular
de 1 kb. Cl. Grupo.
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FIGURE 1C. Restriction enzyme analysis of DNA from
BoHV-1 strains with PstI. 1: Cu7 strain; 2: V214 strain; 3:
USA3 strain; 4: E8 strain; M: 1 kb molecular weight marker.
Cl. Cluster. Arrows indicate the differences between BoHV-
1 strains./ Análisis con enzimas de restricción del ADN de
cepas de BoHV-1 con PstI. 1: Cepa Cu7; 2: Cepa V214; 3:
Cepa USA3; 4: Cepa E8; M: Marcador de peso molecular
de 1 kb. Cl. Grupo. Las flechas indican las diferencias en-
tre cepas de BoHV-1.
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FIGURE 1D. Restriction enzyme analysis of DNA from
BoHV-1 strains with SfiI. 1: VI 273/97 strain; 2: Miggi
strain; 3: V214 strain; 4: E8 strain; M: 1 kb molecular weight
marker. Cl. Cluster. Arrows indicate the differences between
BoHV-1 strains./ Análisis con enzimas de restricción del
ADN de cepas de BoHV-1 con SfiI. 1: Cepa VI 273/97; 2:
Cepa Miggi; 3: Cepa V214; 4: Cepa E8; M: Marcador de
peso molecular de 1 kb. Cl. Grupo. Las flechas indican las
diferencias entre cepas de BoHV-1.
Rev. Salud Anim. Vol. 32 No. 1 (2010)
46
that all strains from Canada and U.S.A were 1.1.I
subtype while 1.1.III subtype was only found in Europe.
The highest number of strains with the same restriction
fragment pattern (71%) was observed by digestion with
HpaI. This can be explained by the small number of
cleavage sites produced by this enzyme, which has
been used for identification of the four major genotypes
of BoHV-1 (11).
The main differences between E8 and the other
bovine herpesviruses analyzed were found in the
restriction fragment patterns obtained by digestion with
PstI and SfiI. This is due to the high number of
restriction sites for these enzymes that can be found
in the genome of BoHV-1. The number of bands
obtained in cluster 3 of E8 strain by digestion with PstI
is not common and it was only found in strains from
Canada, U.S.A, Holland and Belgium according to the
table of classification performed by Wyss (2001).
Taking into account the results obtained by Whetstone
et al (12), it is possible to predict that the differences
in E8 PstI pattern are associated with changes in the
inverted repeat regions. These changes were
observed in restriction endonuclease PstI digestion
patterns of BHV-1.1 and BHV-1.2 isolates after one
passage in host animal. Changes were also observed
when virus was reactivated from latency or after
superinfection with another strain of BHV-1 (13).
It was not possible to find a reference strain with
the same four restriction fragment patterns as the
BoHV-1 E8. The largest number of similar strains was
originated from the European continent, but it has to
be considered that comparison was made with strains
mainly from this region. Considering that the animals
and semen have been imported to the country only
from Canada or USA, it is recommended to increase
the number of entries from de American continent into
the clustering data base. E8 DNA fragment pattern
introduction in this database is a contribution for future
studies in tracing back the origin of novel IBR
outbreaks and is also a contribution to the updating of
the Cuban surveillance epidemiological program but
it is recommended to continue this study with other
Cuban strains.
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